Position in PCVX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$448,240
+$141,710 QoQ
Shares Held
7,711
+46.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#200
of 329 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. PCVX ranks #68 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in PCVX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,240 | 7,711 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $306,530 | 5,275 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $227,562 | 4,932 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $287,943 | 7,994 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $279,976 | 8,612 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $17,730,622 | 469,561 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $25,289,745 | 308,939 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $6,022,256 | 52,702 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $1,390,515 | 18,415 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $1,680,220 | 24,597 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $1,382,101 | 22,008 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $1,102,798 | 21,632 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $1,106,469 | 22,156 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $648,702 | 17,308 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $885,252 | 18,462 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $342,528 | 14,272 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $315,454 | 14,497 | Shares | Defined | 2022-08-10 | |
| 2021-09-30 | $256,769 | 10,121 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $264,762 | 11,762 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $223,451 | 11,314 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $279,436 | 10,517 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||